Public preview. Funding rounds, founders, and growth signals require a free account.

22C Target Pharma Investors Rollover, LLC

Based on SEC filing data. A New York-based LLC founded in 2018 raised $18.2 million in Series A equity funding.

Series ANew York, NY

Total raised

$18.3M

Last round

Equity

$18.3M · Jun 2018

Stage

Series A

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment 22C Target Pharma Investors Rollover, LLC files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.